Nature has provided us with a wide range of high-value therapeutic compounds and Librede’s mission is to tap into these useful compounds in environmentally and economically sustainable ways. Libres yeast-based synthetic biology platform enables access to these compounds unlocking the therapeutic potential of nature. Librede has developed a yeast-based cannabinoid production and drug discovery platform to create chemical compounds that target the endocannabinoid system (ECS). Focusing on the natural cannabinoids found in the cannabis plant, Librede’s modular technology enables large scale production of natural cannabinoids in a more economic and environmentally sustainable way. Fermentation enables low-cost production of ultra-low abundant cannabinoids that are not accessible through agricultural production at an industrial scale. This technology allows access to these therapeutic compounds in a way that is environmentally friendly using no fertilizers or pesticides and less water, land, and energy. Welcome to the future of cannabinoid production!